Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Othman

Showing results (261-270 of 477) with videos related to

Pageof 48
Sort By:
The Journal of the Egyptian Medical Association|January 1, 1978
Effect of smoking on diabetic retinopathyS Aziz, M T El-Gengehy, A Othman, et al.
Clinical Pharmacology in Drug Development|July 11, 2020
Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe SubstrateMohamed-Eslam F Mohamed, Mukul Minocha, Sheryl Trueman, et al.
The Medical Journal of Malaysia|March 20, 2021
Development of hearing impairment inventory for religious duties of Muslim adultS Rahmat, S A Rahman, N H Tukiran, et al.
Journal of Clinical Pharmacology|March 7, 2025
Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver DiseaseIslam R Younis, Elijah J Weber, Cara Nelson, et al.
The Korean Journal of Parasitology|March 10, 2015
Immunopathological changes in the brain of immunosuppressed mice experimentally infected with Toxocara canisMohamed M Eid, Samy I El-Kowrany, Ahmad A Othman, et al.
Clinical Pharmacokinetics|June 9, 2016
Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid ArthritisMohamed-Eslam F Mohamed, Heidi S Camp, Ping Jiang, et al.
Clinical Pharmacology in Drug Development|July 28, 2018
Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 StudiesHoi-Kei Lon, Nuno Mendonca, Sandra Goss, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|August 5, 2018
Bone-borne accelerated sutural expansion: A microcomputed tomography study in rabbitsAkram S Alyessary, Adrian U J Yap, Siti A Othman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementiaLaura M Gault, Craig W Ritchie, Weining Z Robieson, et al.
Asian Journal of Transfusion Science|March 29, 2014
Hepatitis C virus genotypes among multiply transfused hemoglobinopathy patients from Northern IraqAdil A Othman, Adil A Eissa, Raji D Markous, et al.
Pageof 48

Showing results (261-270 of 477) with videos related to

Sort By:
Pageof 48
The Journal of the Egyptian Medical Association|January 1, 1978
Effect of smoking on diabetic retinopathyS Aziz, M T El-Gengehy, A Othman, et al.
Clinical Pharmacology in Drug Development|July 11, 2020
Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe SubstrateMohamed-Eslam F Mohamed, Mukul Minocha, Sheryl Trueman, et al.
The Medical Journal of Malaysia|March 20, 2021
Development of hearing impairment inventory for religious duties of Muslim adultS Rahmat, S A Rahman, N H Tukiran, et al.
Journal of Clinical Pharmacology|March 7, 2025
Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver DiseaseIslam R Younis, Elijah J Weber, Cara Nelson, et al.
The Korean Journal of Parasitology|March 10, 2015
Immunopathological changes in the brain of immunosuppressed mice experimentally infected with Toxocara canisMohamed M Eid, Samy I El-Kowrany, Ahmad A Othman, et al.
Clinical Pharmacokinetics|June 9, 2016
Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid ArthritisMohamed-Eslam F Mohamed, Heidi S Camp, Ping Jiang, et al.
Clinical Pharmacology in Drug Development|July 28, 2018
Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 StudiesHoi-Kei Lon, Nuno Mendonca, Sandra Goss, et al.
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|August 5, 2018
Bone-borne accelerated sutural expansion: A microcomputed tomography study in rabbitsAkram S Alyessary, Adrian U J Yap, Siti A Othman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementiaLaura M Gault, Craig W Ritchie, Weining Z Robieson, et al.
Asian Journal of Transfusion Science|March 29, 2014
Hepatitis C virus genotypes among multiply transfused hemoglobinopathy patients from Northern IraqAdil A Othman, Adil A Eissa, Raji D Markous, et al.
Pageof 48